Tag Archives: biotechnology

Joint Statement of BIO, AAU, ACE, APLU, AUTM and COGR

Earlier today, the United States Supreme Court issued its opinion in the appeal of Stanford University against Roche Diagnostics. This case is of significant interest to the Biotechnology Industry Organization (BIO), Association of American Universities (AAU), American Council on Education (ACE), Association of Public and Land-grant Universities (APLU), Association of University Technology Managers (AUTM), and Council on Governmental Relations (COGR) because of its potential impact on university technology transfer, on development and commercialization of university-generated Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , ,

USPTO Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting

Biotechnology/Chemical/Pharmaceutical Customer Partnership Wednesday, June 8, 2011 Meeting Madison Auditorium Starting Time of 10:00 AM United States Patent and Trademark Office Alexandria, Virginia 600 Dulany Street, Alexandria, VA, Accessing the event: Double click on the link below (or copy it into your internet browser) https://uspto.connectsolutions.com/r80345544/ Click here for detailed login instructions in MS Word. Driving & Metro Directions /Hotels (Word)   Campus Map (html)   Campus Map (Power Point) Morning Session 10:00 – 10:30 AM. Greetings, TC Update Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Beware the Liability Gaps in Biotechnology M&As

Mike Yeager, Senior Underwriting Specialist, Chubb Mergers and acquisitions continue to be a source of growth for the biotechnology industry. Even the financial crisis has not significantly slowed this trend. In fact, a weakened global economy may have further fueled consolidation as biotechnology companies sought additional efficiencies in R&D, procurement or administration. Since many biotechnology companies have complex corporate structures—some with hundreds of subsidiaries—executives at acquiring companies recognize that along with the benefits of the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO World Congress Begins with Newsmakers

BIO’s 2011 World Congress got off to a strong start in Toronto, with news announcements from G2 BioChem and others throughout the morning. The big news from BIO was the presentation of the George Washington Carver Award to Royal DSM CEO/Chairman Feike Sijbesma. Sijbesma discussed the evolution of DSM from a coal mining company to a chemical company and now to a global life sciences and materials company. For Sijbesma, this transformation mirrors the current Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Scientific American Worldview 2011 Preview – Three pioneers share keys to success for building biotech in emerging markets

Three biotech luminaries who have succeeded against all odds share their experiences building a biotech company from the ground up in Brazil, China and India. This year’s report will profile: Guilherme Emrich, FIR Capital (Brazil) Ge Li, WuXi Apptec (China) Kiran Mazumdar-Shaw, Biocon (India) Their opinions and advice on a diverse range of subjects is explored in a Q&A while their individual stories are told in accompanying profiles.  Don’t miss this special section in the Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , ,